Allyx Therapeutics's last reported valuation, Feb 2023. Nothing priced has surfaced since.
- ·Watch Allyx Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Allyx Therapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2026 | Early Stage VC | $26.4M | ▮ | ▮ |
| Feb 2026 | Seed Round | $3.3M | ▮ | ▮ |
| Feb 2023 | Seed Round | $2.3M | ▮ | ▮ |
| May 2021 | Early Stage VC | $7.6M | ▮ | ▮ |
Membership and data by Private Market View
Allyx Therapeutics valuation
Allyx Therapeutics's last reported valuation was $32.3 million in Feb 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Allyx Therapeutics raised?
Allyx Therapeutics has raised $13.2 million across 4 recorded rounds since 2021. The largest was a $7.6 million early-stage round in May 2021; the most recent was a $26.4 million early-stage round in May 2026.
Allyx Therapeutics has filed 2 Form Ds with the SEC since 2021, most recently in Feb 2023 ($2.3 million sold to 11 investors).
How Allyx Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Allyx Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Allyx Therapeutics
- What is Allyx Therapeutics worth?
- Allyx Therapeutics is valued at $32.3M as of Oct 2026. Allyx Therapeutics's last reported valuation, Feb 2023. Nothing priced has surfaced since.
- How much has Allyx Therapeutics raised?
- Allyx Therapeutics has raised $13.2M in total funding across 4 recorded rounds.
- When did Allyx Therapeutics last raise?
- Allyx Therapeutics last raised in May 2026 (Early Stage VC), raising $26.4M.